Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tilray

Tilray Stock Soars Then Returns To Earth On Biden's Cannabis Pardon News, This Analyst Remains Neutral

On the heels of President Biden’s historic announcement that he was pardoning all federal marijuana possession convictions, Cantor Fitzgerald's

Benzinga

S&P 500 Gives Up Early Week Gains Following Latest Jobs Report: Is A Recession Looming?

After a strong two-day rally to start October, the SPDR S&P 500 ETF Trust (NYSE: SPY) gave up some of its gains on Friday following a mixed U.S. jobs report.

Benzinga

Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Canopy Growth, Tilray Pull Back After Enjoying Surge Following Biden's Pardon: What's Up With These Cannabis Stocks?

Canopy Growth Corp. (NASDAQ: CGC) and Tilray Brands Inc. (NASDAQ: TLRY) were plunging over 13% and 11%, respectively, at one point Friday after skyrocketing on Thursday.

Benzinga

Levi Strauss, Tilray Brands And Some Other Big Stocks Moving Lower On Friday

U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording losses in today’s session.

Benzinga

Tilray Net Loss Nearly Doubles From Year Ago, But Biden Marijuana Pardons Keep The Stock Up

Canadian marijuana giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) reported Friday financial results for the first fiscal quarter ended August 31, 2022, with net revenue of $153.2 million, which compares to revenue of $168.02 million for the same period last year.

Benzinga

Want Exposure To The Canadian Recreational Cannabis Market? These Are The 3 Best Picks, According To A Cantor Analyst

In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald offered an update on the performance of Canada’s cannabis Licensed Producers in the August quarter, based on data obtained by the market scanner Hifyre.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Tilray To Guide Patients On Their Medical Cannabis Journey, Launches New Products & 'CannaPoints' Program

Tilray Brands, Inc.’s (Nasdaq: TLRY) (TSX:TLRY) Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands and launched CannaPoints, a new program designed to support pa

Benzinga

Is Tilray Still A Bear Play Or Is The Cannabis Giant Ready For A Big Break North?

Tilray Brands, Inc (NASDAQ: TLRY) was spiking up over 6% on Monday, attempting to break up from a falling channel on the daily chart, which the stock began trading in on Aug. 8.

Benzinga

Why Does This Undervalued Cannabis Stock Have An Encouraging Outlook?

The Analyst

Benzinga

Analysts Going Hard On Tilray, Slashing Price Targets; How Much Adj. EBITDA Really Improved?

Tilray Brands, Inc.

Benzinga

EXCLUSIVE: Tilray CEO Shares Insider Insights Into Earnings, International Opportunities, Alcohol Market & More

Tilray Brands Inc.'s (NASDAQ: TLRY) CEO Irwin Simon said on Thursday's "Cannabis Insider" that "Europe will legalize [cannabis] before the U.S."

Benzinga

Tilray's Fiscal 2022 Revenue Grows 22% YoY, Here Are The Details

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) net revenue grew 8% to $153.3 million during the fourth quarter 2022, from $142.2 million in the prior year quarter.

Benzinga

What's Going On With Tilray Stock As Cannabis Legalization Bill Reaches Senate?

Tilray Brands, Inc (NASDAQ: TLRY) gapped up about 4.5% higher on Thursday on news that the Cannabis Administration And Opportunity Act (CAOA) has been introduced in the U.S. Senate.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Tilray Goes Through With It: Closes $155M Investment In HEXO, Expects $80M In Shared Savings

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) has closed its acquisition from HT Investments MA LLC (“HTI”) of the secured convertible note issued by HEXO Corp. (NASDAQ: HEXO

Benzinga

Tilray's Good Supply Brand Expands Its Cannabis Portfolio In Québec

Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) cannabis brand Good Supply has expanded its product offering in Québec with the launch of Hash-Infused Pre-Rolls, in collaboration with the Société Québ&e

Benzinga

Tilray Will Cover Employees' Travel, Accommodation & Paid Time Off For Women Seeking Reproductive Care

Tilray Brands Inc. (NASDAQ: TLRY) is joining other companies that are committing to help their employees travel to other states, following SCOTUS' decision to overturn Roe v.

Benzinga

Tilray Medical Expands Portfolio Of Medical Cannabis Products In The UK

Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

5 Value Stocks To Watch In The Healthcare Sector

What Defines a Value Stock?

Benzinga

Sentiment For Tilray Stock Should Improve, This Analyst Tells Us Why

Germany is inching toward legalizing recreational cannabis as the government seeks to have the process completed by the end of 2022. The latest push is coming from the country’s Health Ministry which undertook exper

Benzinga

Read Why Cantor Upgraded Aurora Cannabis Stock

Cantor Fitzgerald has upgraded Aurora Cannabis Inc (NASDAQ: ACB) to Overweight from Neutral

Benzinga

Tilray's Medical Cannabis Facility Visited By Government Of Luxembourg Delegation

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) welcomed the Luxembourg Ministry of Health delegation to the company’s European campus and facility located in Cantanhede, Portugal.

Benzinga

HEXO Deal Could Be A Big Win For Tilray, This Analyst Tells Us Why

On Wednesday HEXO Corp (NASDAQ: HEXO) reported a staggering loss of CA$152.7 million ($118 million) in the third quarter of 2022, representing a

Benzinga

HEXO, Tilray Brands Amend Transaction Agreement, Here Are The Details

HEXO Corp. (TSX:HEXO) (NASDAQ: HEXO) has entered into an amending agreement to the transaction agreement with Tilray Brands, Inc. (NASDAQ:

Benzinga

Here's Why More Pain Looks Likely For Tilray Bulls

Tilray Inc (NASDAQ: TLRY) slipped to a new 52-week low on Thursday as the stock continued in a consistent 16-month downtrend that began in February 2021.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.